Best Practices

Use of Urinalysis to Assess Adherence to Prescribed Cardiovascular Medications: Focus on Hypertension

Publish date: March 20, 2018
This supplement is sponsored by Aegis Sciences Corporation.

 

Click here to read the supplement

    Topics include:

    • Common problem of nonadherence to CV medications
    • Nonadherence as a contributor to poor CV outcomes
    • Improvement of adherence in meeting quality payment program criteria
    • Urinalysis as a tool to support adherence
    • Benefits of using the KardiAssure™ urinalysis test

    Click here to read the supplement

    Recommended Reading

    Genotype did not significantly affect evacetrapib response
    MDedge Internal Medicine
    MDedge Daily News: Improving wearable cardioverter defibrillators
    MDedge Internal Medicine
    MOMENTUM 3 HeartMate 3 LVAD ‘practice changing’
    MDedge Internal Medicine
    Barbershop intervention cuts blood pressure in black men
    MDedge Internal Medicine
    VIDEO: Patient vouchers prompt physicians to prescribe top antiplatelet drugs
    MDedge Internal Medicine
    MDedge Daily News: Why the barber’s chair can help hypertension
    MDedge Internal Medicine
    Abstract: Electrocardiograms in Low-Risk Patients Undergoing an Annual Health Examination
    MDedge Internal Medicine
    MDedge Daily News: Could gut bacteria trigger autoimmune diseases?
    MDedge Internal Medicine
    Radial access PCI best for acute coronary syndrome patients
    MDedge Internal Medicine
    Febuxostat increases cardiovascular mortality in CARES trial
    MDedge Internal Medicine